Elevated cutaneous Smad activation associates with enhanced skin tumor susceptibility in organ transplant recipients

PURPOSE: Non-melanoma skin cancer incidence is enhanced over fifty fold in patients taking anti-rejection drugs (ARDs) following organ transplantation. Pre-clinical studies suggest that ARD treatment increases transforming growth factor β1 (TGF-β1) levels, which contribute to enhanced tumor suscepti...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Harradine, Kelly A., Ridd, Katie, Saunier, Elise F., Clermont, Frederic F., Perez-Losada, Jesus, Moore, Dan H., Epstein, Ervin H., Bastian, Boris C., Akhurst, Rosemary J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2812428/
https://ncbi.nlm.nih.gov/pubmed/19671862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-3286
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky